US2008190845A1PendingUtilityA1
Methods for Enhancing the Dewaterability of Sludge with Alpha-Amylase Treatment
Est. expirySep 2, 2025(expired)· nominal 20-yr term from priority
C02F 9/00C02F 11/121C02F 3/34C02F 2303/06C02F 3/342C02F 2103/28C02F 11/147
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to enhancing sludge dewaterability by adding an alpha-amylase to the sludge prior to conventional conditioning and dewatering operations.
Claims
exact text as granted — not AI-modified1 . A method for enhancing the dewaterability of sludge comprising adding an alpha-amylase to the sludge prior to mechanical dewatering equipment.
2 . The method of claim 1 , wherein the alpha-amylase is derived from a strain of Geobacillus stearothermophilus.
3 . The method according to claim 1 , wherein the alpha-amylase has at least 80% identity to the alpha-amylase shown in SEQ ID NO: 1 as determined using the Clustal method (Higgins, 1989, CABIOS 5: 151-153) using the LASERGENE™ MEGALIGN™ software (DNASTAR, Inc., Madison, Wis.) with an identity table and the following multiple alignment parameters: Gap penalty of 10 and gap length penalty of 10. Pairwise alignment parameters are Ktuple=1, gap penalty=3, windows=5, and diagonals=5.
4 . The method according to claim 1 , wherein the alpha-amylase has at least 80% identity to a Geobacillus stearothermophilus alpha-amylase as determined using the Clustal method (Higgins, 1989, CABIOS 5: 151-153) using the LASERGENE™ MEGALIGN™ software (DNASTAR, Inc., Madison, Wis.) with an identity table and the following multiple alignment parameters: Gap penalty of 10 and gap length penalty of 10. Pairwise alignment parameters are Ktuple=1, gap penalty=3, windows=5; and diagonals=5.
5 . The method according to claim 1 , wherein the dose of alpha-amylase is between 2 and 140 g per dry ton of total suspended solids.
6 . The method according to claim 1 , wherein the dose of alpha-amylase is between 2 and 70 g per dry ton of total suspended solids.
7 . The method according to claim 1 , wherein the dose of alpha-amylase is between 2 and 35 g per dry ton of total suspended solids.
8 . The method according to claim 1 , wherein the dose of alpha-amylase is between 2 and 8 g per dry ton of total suspended solids.
9 . The method according to claim 1 , wherein the dose of alpha-amylase is between 2 and 5 g per dry ton of total suspended solids.
10 . The method according to claim 1 , wherein the enzyme is allowed to incubate with the sludge for 1 minute to 24 hours.
11 . The method according to claim 1 , wherein the enzyme is allowed to incubate with the sludge for 30 minutes to 12 hours.
12 . The method according to claim 1 , wherein the enzyme is allowed to incubate with the sludge for 1 hour to 2 hours.
13 . The method according to claim 1 , wherein the sludge is generated during conventional municipal and industrial wastewater treatment operations.
14 . The method according to claim 5 , wherein the sludge is selected from the group consisting of primary sludge from primary clarifiers, waste activated sludge, return activated sludge, anaerobically digested sludge and aerobically digested sludge.
15 . The method according to claim 2 , wherein the alpha-amylase is added in combination with one or more proteases, lipases, cellulases, a hemicellulases, oxidoreductases, laccases, glycosyl hydrolases and/or an esterases.
16 . A method for enhancing the dewaterability of sludge comprising adding an alpha-amylase to the sludge prior to mechanical dewatering equipment, wherein the alpha-amylase is derived from a strain of Geobacillus stearothermophilus or is an alpha-amylase having an amino acid sequence which has at least 80% identity to the alpha-amylase shown in SEQ ID NO: 1.
17 . The method according to claim 16 , wherein the alpha-amylase is derived from a strain of Geobacillus stearothermophilus.
18 . The method according the claim 16 , wherein the alpha-amylase is an alpha-amylase having an amino acid sequence which has at least 80% identity to the alpha-amylase shown in SEQ ID NO: 1, at least 85% identity to the alpha-amylase shown in SEQ ID NO: 1, at least 90% identity to the alpha-amylase shown in SEQ ID NO: 1, at least 95% identity to the alpha-amylase shown in SEQ ID NO: 1, at least 96% identity to the alpha-amylase shown in SEQ ID NO: 1, at least 97% identity to the alpha-amylase shown in SEQ ID NO: 1, at least 98% identity to the alpha-amylase shown in SEQ ID NO: 1, at least 99% identity to the alpha-amylase shown in SEQ ID NO: 1.
19 . The method according to claim 16 , wherein the alpha-amylase has the amino acid sequence of SEQ ID NO: 1.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.